Jump to any asset
849 assets, updated daily
As of October 11, 2026, The Procter & Gamble Company (PG) trades at $151.23. CleaRank Financial AI rates it Hold with a fair value of $151.23, in line with the current price. Wall Street's consensus target is $162.00 across 25 analysts. RSI at 62 is in neutral territory, and the price is above its 50-day average of $145.91.
The Procter & Gamble Company (PG)
The Procter & Gamble Company NYSE
$151.23
0.6400 (0.42%)
At close: Oct 9, 4:00 PM EDT
AI Analyst Consensus
59 / 100
The Procter & Gamble Company (PG) is currently trading at $151.23, precisely at its calculated fair value, reflecting a neutral near-term outlook. The company's recent earnings beat for the quarter to June 2026, with EPS of $1.43 against an estimate of $1.41, was overshadowed by a 1.46% stock price decline, indicating muted investor reaction. Despite this, Wall Street maintains a 'Hold' consensus with a median price target of $162.00, suggesting a modest 7.1% upside potential from current levels. The company's consistent revenue growth of 1.5% and strong profit margins of 18.44% are foundational, but are tempered by significant insider selling totaling $88.4 million, signaling potential caution from management. PG's valuation metrics, including a P/E ratio of 22.75, are slightly below the sector average of 24.2, and its price-to-sales ratio of 4.02 is above the sector median of 2.2, suggesting a premium valuation on sales. The company's return on equity stands at a strong 30.29%, well above the sector average of 19.7%, indicating efficient capital utilization. However, the substantial insider selling, categorized as a heavy insider selling, presents a key risk that investors should monitor closely, potentially outweighing the stability offered by its consumer defensive sector positioning.
PG Price Analysis
Market Metrics
Open
$150.57
Day Range
$149.92 to $151.60
Prev Close
$150.59
Volume
6.31M
52-Week Range
$137.62 to $167.25
Market Cap
$351.26B
Peer Benchmarking
Valuation vs Sector (Consumer Defensive)
Performance vs VDC
Sector Position Analysis
Valuation is broadly in line with sector peers (-6% difference), suggesting fair market pricing relative to industry standards.
PG Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 5 quarters, PG beat estimates 4 times. However, the stock fell 2 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
PG Analysis
Company's Health
4/5
12-Month Analyst Target
+7.12% Upside
Median of 25 analysts (12-month)
$162.00
AI Technical Analysis
Volume has decreased by 26.7% compared to its average, indicating a lack of strong conviction in recent price action. The Procter & Gamble Company (PG) is trading above its 50-day and 200-day moving averages ($145.91 and $147.74), suggesting a generally positive but not aggressively bullish trend. The Relative Strength Index (RSI) is at 61.94, indicating bullish momentum without being overbought, while the MACD at 0.86 suggests a positive trend. The stock is also trading above its 20-day EMA ($147.26), reinforcing the current upward bias. Key support levels are found near the 50-day SMA, while resistance may emerge around the recent highs. The current technical setup, with multiple moving averages acting as support and a bullish RSI, points towards continued stability. However, the declining volume alongside these positive indicators could suggest that the upward momentum may not be sustainable without further fundamental catalysts or increased investor participation.
ProTips
- Monitor insider transaction activity closely, as the recent heavy insider selling with $88.4 million in sales could indicate management's sentiment regarding future performance.
- Given the stock is trading at its fair value and analyst targets suggest limited upside, consider taking profits or waiting for a more compelling entry point, especially if the price approaches the median target of $162.00.
- The company's strong brand loyalty and defensive sector positioning offer stability, but revenue growth is projected to remain modest at around 2%, suggesting that significant capital appreciation may be limited in the near term.
Key Catalysts
Bearish
Significant Insider Selling Pressure
Insiders have sold a total of $88.4 million in stock, with the insider verdict indicating heavy insider selling, suggesting potential concerns about future performance or valuation from management.
Source: Insider TransactionsNeutral
Stable Revenue Growth Projections
Analysts project revenue growth of approximately 2.00% for both the current and next fiscal year, indicating continued stability but limited acceleration for The Procter & Gamble Company.
Source: Wall Street EstimatesNeutral
Mixed Earnings Reaction
Despite beating EPS estimates in the most recent quarter (Q2 2026), the stock price declined 1.46%, indicating that positive earnings news may not be translating into immediate stock appreciation.
Source: Earnings ReportsBullish
Strong Return on Equity
The company's return on equity stands at a strong 30.29%, significantly outperforming the sector average, highlighting efficient capital management and profitability.
Source: Company FundamentalsMarket Outlook
The base case scenario for The Procter & Gamble Company (PG) suggests continued stability with potential for modest upside, targeting a median analyst price of $162.00 within the next 6-12 months. This outlook is supported by its strong brand portfolio, consistent revenue growth projected at 2.00% for the current and next year, and efficient operations reflected in its high return on equity. The company's positioning within the defensive consumer staples sector provides a degree of resilience against broader market volatility. However, the thesis could be challenged by continued heavy insider selling, which signals potential underlying concerns not fully captured by financial metrics. A significant downside risk would be a shift in consumer spending patterns or increased competitive pressure that impacts PG's market share and growth trajectory. Upside catalysts could emerge from successful new product launches or strategic acquisitions that expand its market reach and revenue streams, though current analyst estimates do not price in substantial acceleration.
Key Statistics
| Market Cap | 351.26B |
|---|---|
| P/E Ratio | 22.75 |
| EPS (TTM) | 6.62 |
| Dividend Yield | 2.84% |
| 52 Week High | 167.25 |
| 52 Week Low | 137.62 |
The Procter & Gamble Company (PG) exhibits a P/E ratio of 22.75, which is slightly below the sector average of 24.2, suggesting a potentially attractive valuation relative to its peers on earnings. However, its price-to-sales ratio of 4.02 is notably higher than the sector median of 2.2, indicating that the market values its sales less favorably compared to its earnings. The company's return on equity is a strong 30.29%, significantly outperforming the sector average of 19.7%, demonstrating excellent profitability and efficiency in generating returns for shareholders. PG's profit margin of 18.44% and operating margin of 22.08% are strong, reflecting strong operational performance and pricing power within the consumer defensive sector. The debt-to-equity ratio of 0.64 is within a reasonable range, though slightly above the sector average, indicating a moderate level of leverage. While the company's fundamentals are generally solid, the valuation appears somewhat stretched on a price-to-sales basis, warranting a cautious approach.
Earnings & Growth Analysis
The Procter & Gamble Company (PG) most recently reported earnings for the quarter to June 2026, delivering an EPS of $1.43, a slight beat against the analyst estimate of $1.41, representing a 1.42% surprise. Despite this positive earnings surprise, the stock experienced a 1.46% decline, suggesting that the market may have anticipated stronger performance or that other factors are weighing on sentiment. Prior quarters show a mixed pattern of beats and misses, with a notable miss in the quarter to March 2026 (EPS actual $1.50 vs. estimate $1.57, -4.46% surprise). The company's revenue growth is projected at a modest 2.00% for the next quarter and current year, indicating stable but not rapid expansion.
Key Risks
Significant insider selling, with total sales reaching $88.4 million and a heavy insider selling, represents a primary risk, suggesting potential management concerns despite positive operational metrics. The company's price-to-sales ratio of 4.02, which is above the sector median of 2.2, indicates a potential valuation stretch on sales that could limit upside. Also, the muted market reaction to recent earnings beats, as seen in the quarter to June 2026, highlights a potential lack of investor enthusiasm or broader market headwinds impacting consumer defensive stocks.
Technical Indicators
| RSI (14) | 61.94 |
|---|---|
| MACD | 0.86 |
| SMA 50 | 145.91 |
| SMA 200 | 147.74 |
RSI
Bullish
SMA Cross
Bearish
Price vs SMA
Bullish
MACD
Bullish
Moving averages show a lagging Death Cross (50-day: $145.91, 200-day: $147.74), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.08
Weak correlation
Nasdaq 100 (QQQ)
-0.07
Weak correlation
Bitcoin (BTC)
-0.16
Weak correlation
Gold (XAU)
+0.07
Weak correlation
Check Custom Correlation
How does any other asset move with PG? One year of daily closes, Pearson correlation.
Try
PG Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$149.72
Slight discount to current
Wait for small dip
Aggressive
$151.23
At current price
Enter now if confident
Risk Management
STOP LOSS
$145.23
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (61.9) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$154.21
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$157.20
+5% (Conservative)
+3.9% (Aggressive)
TARGET 3
$161.70
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for PG is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on October 11, 2026.Growth of $10,000
A $10,000 investment in PG in October 2016 would be worth about $17,080 today, compared with about $36,479 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PG today could grow to about $18,402 by 2036 in the base case, with a bull case near $40,208 and a bear case around $8,422. Projections are statistical simulations, not guarantees.
PG Stock Price Prediction: 2030
CleaRank's simulation projects a price near $193 for PG by 2030 in the base case, from $151 today (1.3x over 4 years). The downside path ends near $118. These are outcomes of a Monte Carlo simulation run on PG's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $126 | $161 | $206 |
| 2028 | $120 | $171 | $242 |
| 2029 | $118 | $182 | $279 |
| 2030 | $118 | $193 | $316 |
| 2031 | $118 | $205 | $357 |
| 2032 | $119 | $218 | $399 |
| 2033 | $121 | $232 | $446 |
| 2034 | $122 | $246 | $496 |
| 2035 | $125 | $262 | $550 |
| 2036 | $127 | $278 | $608 |
Method: 10,000 simulated price paths using PG's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
PG Insider Trading Analysis
Bought
None
No open-market buys
Sold
$88.4M
45 Transactions
Insiders
30
Active Traders
Avg Transaction
$2.0M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 6, 2021 | PELTZ NELSON
Director
|
Sell | 2.8M | $371.8M |
| Aug 27, 2020 | PELTZ NELSON
Director
|
Sell | 697.0K | $96.8M |
| Feb 17, 2021 | PELTZ NELSON
Director
|
Sell | 530.0K | $68.1M |
| Feb 3, 2021 | PELTZ NELSON
Director
|
Sell | 408.9K | $52.6M |
| Jan 28, 2022 | MOELLER JON R
Chief Executive Officer
|
Sell | 281.3K | $45.2M |
| Aug 10, 2021 | PELTZ NELSON
Director
|
Sell | 315.3K | $44.8M |
| Nov 30, 2020 | PELTZ NELSON
Director
|
Sell | 306.6K | $42.1M |
| Aug 31, 2021 | PELTZ NELSON
Director
|
Sell | 207.0K | $29.5M |
| Aug 15, 2022 | MOELLER JON R
Chief Executive Officer
|
Sell | 193.3K | $28.4M |
| Feb 12, 2026 | MOELLER JON R
Officer and Director
|
Sell | 173.3K | $28.1M |
Page 1 of 1
Frequently Asked Questions
Is The Procter & Gamble Company stock a buy right now?
The Procter & Gamble Company (PG) is currently trading at $151.23, which is its calculated fair value. Wall Street analysts have a 'Hold' consensus rating, with a median price target of $162.00, suggesting limited upside of 7.1%. Significant insider selling also warrants caution.
What is PG stock's price forecast for 2030?
Based on Monte Carlo simulations, The Procter & Gamble Company's (PG) stock price is projected to reach a base case of $193.01 by 2030, with a downside projection of $117.73 and an upside projection of $316.43. These are statistical outcomes, not guarantees.
How has The Procter & Gamble Company performed in recent earnings reports?
In the quarter to June 2026, PG reported EPS of $1.43, beating estimates by 1.42%, though the stock declined 1.46%. The company has shown a mixed earnings surprise history in recent quarters.
What are the key financial strengths of The Procter & Gamble Company?
The Procter & Gamble Company boasts a strong return on equity of 30.29%, significantly above the sector average, and maintains strong profit margins of 18.44%. Its revenue growth is stable at 1.5%.
What are the main risks facing The Procter & Gamble Company?
A significant risk is the heavy insider selling totaling $88.4 million, indicating potential management caution. Additionally, the stock's price-to-sales ratio is above the sector median, and recent earnings beats have not translated into positive stock performance.
How does The Procter & Gamble Company's valuation compare to its sector?
The Procter & Gamble Company's P/E ratio of 22.75 is below the sector average of 24.2, but its price-to-sales ratio of 4.02 is above the sector median of 2.2. Its return on equity of 30.29% significantly outperforms the sector average of 19.7%.
What is the Wall Street consensus for PG stock?
Wall Street analysts collectively hold a 'Hold' consensus rating for The Procter & Gamble Company (PG), supported by a score of 59 out of 100. This is based on 25 analysts, with 11 rating it 'Hold', 8 'Buy', and 6 'Strong Buy'.